Inflammatory compounds: Neuropeptide substance P and cytokines

European Journal of Inflammation

Volumn 7, Issue 2, 2009, Pages 63-69

  Castellani, Maria Luisa ^a   Felaco, P ^a   Pandolfi, F ^b   Salini, V ^a   De Amicis, D ^a   Vecchiet, J ^a   Tete S ^a   Ciampoli, C ^a   Conti, F ^a   Cerulli, G ^c   Caraffa, A ^c   Antinolfi, P ^c   Cuccurullo, C ^a   Perrella, A ^d   Theoharides, T C ^e   De Lutiis, M A ^a   Kempuraj, D ^e   Shaik, Y B ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Cytokine; Inflammation; Neuropeptide

Indexed keywords

BRADYKININ; CHEMOKINE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5; CORTICOSTEROID; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; NEUROKININ A; NEUROPEPTIDE; RANTES; RECOMBINANT INTERLEUKIN 3; SUBSTANCE P;

ALLERGY; ARTHRITIS; ASTHMA; AUTOIMMUNE DISEASE; BURN; CHEMOTAXIS; FEVER; HUMAN; INFLAMMATION; NERVE ENDING; PATHOPHYSIOLOGY; REVIEW; SEPSIS; TISSUE INJURY;

EID: 69549127777     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727x0900700202     Document Type: Review

References (77)

1. Feuerstein G, Hallenbeck JM. Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol 1987; 27:301-313 (Pubitemid 17067237)
2. Cinque B, Fanini D, Di Marzio L, et al. Involvement of cPLA2 inhibition in dexamethosone-induced thymocyte apoptosis. In J Immunpathol Pharmacol 2008; 21:539-551
3. Saria A. Neuroimmune interactions in the airways: implications for asthma, allergy, and other inflammatory airway diseases. Brain Behav Immun 1988; 2:318-321
4. Liu D, Jiang LS, Dai LY Substance P and its receptors in bone metabolism. Neuropeptides 2007; 41:271-283
5. Rittner HL, Brack A, Stein C. Pain and the immune system. Br J Anaesth 2008; 101:40-44
6. Castellani ML, Conti P, Felaco M, Vecchiet J, Ciampoli C, Cerulli G, Boscolo P, Theoharides TC. Substance P upregulates LTB in rat adherent macrophages from granuloma induced by KMnO. Neurotox Res 2009; 15:49-56.
7. Shephard RJ. Cytokine responses to physical activity, with particular reference to IL-6: sources, actions, and clinical implications. Crit Rev Immunol 2002; 22:165-182
8. Tarantino G, Coppola A, Conca P, Cimino E, Di Minno G. Can serum TGF-beta be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? In J Immunopathol Pharmacol 2008; 21:1007-1012
9. Martino G, Grohovaz F, Brambilla E, et al. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients. Ann Neurol 1998; 43:340-349 (Pubitemid 28113597)
10. Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann NY Acad Sci 2006; 1069:62-76. (Pubitemid 43989851)
11. Sisto M, D'Amore M, Scagliusi P, Mitolo V, Lisi S. Selective TNF-alpha gene silencing attenuates apoptosis in human salivary gland epithelial cells. Int J Immunopathol Pharmacol 2008; 21:1045-1047
12. Mitola S, Sorbello V, Ponte E, et al. Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease. Int J Immunopathol Pharmacol 2008; 21:851-865
13. Clark N, Keeble J, Fernandes ES, Starr A, Liang L, Sugden D, de Winter P, Brain SD. The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J 2007; 21:3747-3755 (Pubitemid 350075162)
14. Piancatelli D, Bellotta L, Del Beato T, Duse M, Della Penna MR. Total IL-12 levels are increased in paediatric atopic dermatitis: correlations with age and disease severity. Int J Immunopathol Pharmacol 2008; 21:359-365 (Pubitemid 351988398)
15. Moschese V, Graziani S, Avanzini MA, et al. A prospective study on children with initial diagnosis of transient hyopogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol 2008; 21:343-352 (Pubitemid 351988396)
16. Bernardini R, Pucci N, Rossi ME, et al. Allergen specific nasal challenge to latex in children with latex allergy: clinical and immunological evaluation. In J Immunopathol Pharmacol 2008; 21:333-341 (Pubitemid 351988395)
17. Calcagni E, Elenkov I.Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann NY Acad Sci 2006; 1069:62-76. (Pubitemid 43989851)
18. Calvisi V, Lupparelli S. C-reactive protein changes in the uncomplicated course of arthroscopic anterior cruciate ligament reconstruction. Int J Immunopathol Pharmacol 2008; 21:603-607
19. Vivas JR, Regnault B, Michel V, et al. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol 2008; 21:515-526
20. Fulgenzi A, Ticozzi P, Gabel CA, Dell'Antonio G, Quattrini A, Franzone JS, Ferrero ME. Periodate oxidized ATP (oATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapy. Int J Immunopathol Pharmacol 2008; 21:61-71.
21. Ishizuka K, Sugimura K, Homma T, et al. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis. Digestion 2001; 63:22-27 (Pubitemid 32098436)
22. Guerriero C, Manco S, Paradisi A, Capizzi R, Fossati B, Fabrizi G. Extragenital lichen sclerosus and atrophicus treated with topical steroids and retinoids in a child with vitiligo. Int J Immunopathol Pharmacol 2008; 21:757-759
23. Cordiali-Fei P, Ardigò M, Mastroianni A, et al. Serum cytokines and vioumoral immunological characterization of psoriatic patients in long term etanercept treatment. In J Immunopathol Pharmacol 2008; 21:643-649
24. Stratta P, Marcuccio C, Campo A, et al. Improvement in relative survival of patients with vasculitis: study of 101 cases compared to the general population. Int J Immunopathol Pharmacol 2008; 21:631-642
25. Kasai T, Inada K, Takakuwa T, et al. Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1997; 98:34-42. (Pubitemid 28007620)
26. Castellani ML, Shaik YB, Perrella A, et al. Expression and secretion of CXCL8 (IL-8), release of tryptase and transcription of histidine decarboxylase mRNA by anti-IgE-activated human umbilical cord blood-derived cultured mast cells. Neuroimmunomodulation 2007; 14:97-104. (Pubitemid 47442988)
27. Marcucci F, Incorvaia C, Sensi L, et al. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunopathol Pharmacol 2008; 21:609-613
28. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokines and bone remodelling. Int J Immunopathol Pharmacol 2008; 21:585-591
29. Castellani ML, Ciampoli C, Felaco M, et al. Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. Clin Invest Med 2008; 31:E362-72.
30. Di Gioacchino M, Perrone A, Petrarca C, et al. Early cytokine modulation after the repid induction phase of sublingual immunotherapy with monomeric allergoids. Int J Immunopathol Pharmacol 2008; 21:969-976
31. Bost KL. Tachykinin-mediated modulation of the immune response. Front Biosci 2004; 9:3331-3332
32. Koon HW, Zhao D, Zhan Y, Simeonidis S, Moyer MP, Pothoulakis C. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther 2005; 314:1393-1400 (Pubitemid 41206007)
33. Inoue K, Takano H, Yanagisawa R, et al. Antioxidative role of interleukin-6 in septic lung injury in mice. Int J Immunopathol Pharmacol 2008; 21:501-507
34. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008; 123:398-410. (Pubitemid 351171192)
35. Dunzendorfer S, Kaser A, Meierhofer C, Tilg H, Wiedermann CJ. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001; 166:2167-2172 (Pubitemid 32173444)
36. Ciardelli L, Garofoli F, Stronati M, et al. Human colostrum T lymphocytes and their effector cytokines actively aid the development of the newborn immune system. Int J Immunopathol Pharmacol 2008; 21:781-786
37. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008; 123:398-410. (Pubitemid 351171192)
38. Vojdani A. Antibodies as predictors of complex autoimmune diseases and cancer. Int J Immunopathol Pharmacol 2008; 21:553-566
39. Nitschke M, Sohn K, Dieckmann D, Gibbs BF, Wolff HH, Amon U. Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells. Arch Dermatol Res 1996; 288:463-468 (Pubitemid 26282741)
40. Hauswith AW, Excribano L, Prados A, et al. CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking. Int J Immunopathol Pharmacol 2008; 21:797-806.
41. Fiebich BL, Schleicher S, Butcher RD, Craig A, Lieb K. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol 2000; 165:5606-5611 (Pubitemid 30836170)
42. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997; 137:843-850
43. Noguchi K, Yamashiro S, Matsuzaki T, Sakanashi M, Nakasone J, Miyagi K, Sakanashi M. Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits. Br J Pharmacol 2001; 133:395-405. (Pubitemid 33027776)
44. Speranza L, Franceschelli S, Pesce M, Vinciguerra I, De Lutiis MA, Grilli A, Felaco M, Patruno A. Phosphodiesterase type-5 inhibitor and oxidative stress. Int J Immunopathol Pharmacol 2008; 21:879-89.
45. Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 2006; 126:1937-1947 (Pubitemid 44244839)
46. Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 2008; 8:460-471
47. Putignani L, Antonucci G, Paglia MG, Vincenzi L, Festa A, De Mori P, Loiacono L, Visca P. Cryptococcal lymphadenitis as a manifestation of immune reconstitution inflammatory sindrome in an HIV-positive patient: a case report and review of the literature. Int J Immunopathol Pharmacol 2008; 21:751-756
48. Pascual DW. The role of tachykinins on bacterial infections. Front Biosci 2004; 9:3209-3217
49. Papahariadou M, Kalogeromitros D, Athanasiadis GI, et al. Autoimmunity and parasites. Int J Immunopathol Pharmacol 2008; 21:5-9.
50. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21:1-4.
51. Gelardi M, Maselli del Giudice A, Fiorella ML, Fiorella R, Russo C, Soleti P, Di Gioacchino M, Ciprandi G. Non-allergic rhinitis with eosinophils and mast cells constitutes a new severe nasal disorder. Int J Immunopathol Pharmacol 2008; 21:325-331 (Pubitemid 351988394)
52. De Berardis D, Conti CM, Campanella D, et al. Evaluation of C-reactive proetin and total serum cholesterol in adult patients with bipolar disorder. Int J Immunopathol Pharmacol 2008; 21:319-324 (Pubitemid 351988393)
53. Bost KL. Tachykinin-mediated modulation of the immune response. Front Biosci 2004; 9:3331-3332
54. Stanisz AM, Scicchitano R, Dazin P, Bienenstock J, Payan DG. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol 1987; 139:749-754 (Pubitemid 17107071)
55. Izzi V, Chiurchiù V, D'Aquilio F, Martino A, Tresoldi I, Modesti A, Baldini PM. Endomorphin-1 inhibits the activation and the development of a hyporesponsive-like phenotype in lipopolysaccharide-stimulated THP-1 monocytes. Int J Immunopathol Pharmacol 2008; 21:833-843
56. Chan CP, Lei HY. Autophagy induction in T cell-independent acute hepatitis induced by concanavalin A in SCID/NOD mice. Int J Immunopathol Pharmacol 2008; 21:817-826
57. Minardi D, Ghiselli R, Lucarini G, et al. Activity and expression of nitrix oside sythase in rat bladder after sacral neurmodulation. Int J Immunopathol Pharmacol 2008; 21:129-135
58. + cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2. Int J Immunopathol Pharmacol 2008; 21:867-877
59. Lalle E, Sacchi A, Abbate I, et al. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int J Immunopathol Pharmacol 2008; 21:161-171
60. Kalogeromitros C, Makris M, Chliva C, Aggelides X, Kempuraj D, Theoharides TC. A quercetin containing supplement reduces niacin-induced flush in humans. Int J Immunopathol Pharmacol 2008; 21:s509-14.
61. Patriarca G, Schiavino D, Lombardo C, Altomonte G, De Cinti M, Buonuomo A, Numera E. Tolerability of aztreonam in patients with IgE-mediated hypersenitivity to beta-lactams. Int J Immunopathol Pharmacol 2008; 21:375-379 (Pubitemid 351988400)
62. Capodicasa E, Cornacchine P, Natalizi B, Bartolo A, Coaccioli S, Marconi P, Scaringi L. Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes. Int J Immunopathol Pharmacol 2008; 21:73-85.
63. Pifferi M, Caramella D, Ragazzo V, Cangiotti AM, Macchia P, Boner AL. Bronchiectasis in children with recurrent pneumonia: an immunopathological damage associated with secondary cilary dysmotility Int J Immunopathol Pharmacol 2008; 21:215-219
64. De Vita G, Patti R, Sparacello M, Balistreri CR, Candore G, Caruso C. Impact of different texture of polypropylene mesh on the inflammatory response. Int J Immunopathol Pharmacol 2008; 21:207-214
65. Katsanos GS, Anogianaki A, Castellani M, et al. Biology of neurotensin: revisited study. Int J Immunopathol Pharmacol 2008; 21:255-259
66. Sonneck K, Baumgartner C, Rebuzzi I, et al. Recomvinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients. Int J Immunopathol Pharmacol 2008; 21:11-21.
67. Ciccocioppo F, Lanuti P, Marchisio M, et al. Expression and phosphorylation of protein kinase C isoforms in Abeta(1-42) activated T lymphocytes from Alzheimer's disease. Int J Immunopathol Pharmacol 2008; 21:23-33.
68. Minardi D, Lucarini G, Filoa A, Milanese G, Zizzi A, Di Primio R, Montironi R, Muzzonigro G. Prognostic role of tumor necrosis, microvessel density, bascular endothelial growth factory and hypoxia inducile factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a longterm follow-up. Int J Immunopathol Pharmacol 2008; 21:447-455 (Pubitemid 351988410)
69. Raffaelli L, Serini S, Piccioni E, Manicone PF, Berardi D, Perfetti G, Calviello G. N-3 plyunsaturated fatty acid effect in periodontal disease: sstate of art and possibile mechanisms involved. Int J Immunopathol Pharmacol 2008; 21: 261-266 (Pubitemid 351988387)
70. Colanardi MC, Nettis E, Traetta P, Delle Donne P, Ferrannini A, Vacca A. Parecoxib a san alternative in COX-2 hypersensitivity. Int J Immunopathol Pharmacol 2008; 21:233-235
71. Capsoni F, Ongari AM, Frigerio E, Taglioni M, Altomare GF. Effect of Efalizumab on neutrophil and monocyte functions in patients with psoriasis. Int J Immunopathol Pharmacol 2008; 21:437-445 (Pubitemid 351988409)
72. Ferdinande L, Demetter P, Perez-Novo C, Waeytens A, Taildeman J, Rottiers I, Rottiers P, De Vos M, Cuvelier CA. Inflamed intestinal mucosa features a specific epthelial expression pattern of indoleamine 2,3-dioxygenase. Int J Immunopathol Pharmacol 2008; 21:289-295 (Pubitemid 351988390)
73. Vojdani A. Antibodies as predictors of complex autoimmune diseases. Int J Immunopathol Pharmacol 2008; 21:267-278 (Pubitemid 351988388)
74. Balthasar N, Coppari R, McMinn J, et al. Leptin receptor signalling in POMC neurons is required for normal body weight homeostasis. Neuron 2004; 42:983-991 (Pubitemid 38798236)
75. Inoue K, Takano H, Ohnuki M, Yanagisawa R, Sakurai M, Shimada A, Mizushima K, Yoshikawa T. Size effects of nanomaterials on lung inflammation and coagulatory disturbance. Int J Immunopathol Pharmacol 2008; 21:197-206
76. Capoluongo E, Vwento G, Lulli P, et al. Epithelial lining fluid neutrophil-gelatinase-associated lipocalin levels in premature newborns with bronchopulmonary dysplasia and patency of ductus arteriosus. Int J Immunopathol Pharmacol 2008; 21:173-179
77. Cardelli P, Ferraironi M, Amodeo R, et al. Evaluation of neutrophil CD64 expression and preocalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008; 21:43-49